ArticleClinical and translational medicine2026
TALDO1 promotes lipid metabolic reprogramming and immunosuppressive microenvironment remodelling in hepatocellular carcinoma.
Fenglin Lv et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.